Skip to main content
. 2010 Aug 30;3:301–309. doi: 10.2147/DMSOTT.S12375

Table 5.

Comparison of metabolic variables in 444 study subjects according to the cut-off point 0.357 of the QUICKI index

Study groups
QUICKI ≥ 0.357
n = 186
QUICKI < 0.357
n = 258
Metabolic syndrome (%) 15.6 62.4*
Age (years) 39.2 ± 10.9 37.8 ± 12.1
BMI (kg/m2) 25.8 ± 3.8 30.3 ± 5.1**
WC (cm) 86.7 ± 10.0 98.3 ± 12.1***
%BF 29.9 ± 8.4 36.6 ± 6.7**
FH-T2D (%) 55.9 62.8
SBP (mm Hg) 103.8 ± 12.9 110.8 ± 14.4***
DBP (mm Hg) 69.4 ± 8.7 74.8 ± 9.5**
Gluc0h (mg/dL) 88.1 ± 8.1 100.8 ± 22.0**
Ins0h (μU/mL) 4.8 ± 1.4 11.9 ± 4.9**
HOMA-IR 1.1 ± 0.3 3.0 ± 1.6**
HOMA-β 76.5 ± 40.7 126.9 ± 61.3**
HDL-C (mg/dL) 47.6 ± 12.9 39.6 ± 9.6**
TAG (mg/dL) 109.7 ± 50.8 172.3 ± 86.5**
TAG/HDL-C 2.5 ± 1.5 4.8 ± 3.0**
CVI 4.2 ± 1.3 5.1 ± 1.3***

Notes: Results are expressed as mean ± standard deviation.

*

P ≤ 0.05, Fisher’s exact test for two proportions;

**

P ≤ 0.05, Mann–Whitney U test;

***

P ≤ 0.05, Kruskal–Wallis one-way analysis of variance.

Abbreviations: BMI, body mass index; WC, waist circumference; %BF, % body fat; SBP, systolic blood pressure; DBP, diastolic blood pressure; Glc0h, fasting glucose; Ins0h, fasting insulin; HDL-C, cholesterol combined with high-density lipoprotein; TAG, triacylglycerides; HOMA-IR, homeostatic model assessment of insulin resistance; HOMA-β, homeostatic model assessment of β-cell function; QUICKI, index to check the quantitative insulin sensitivity; FH-T2D, family history of type 2 diabetes mellitus; CVI, Castelli Cardiovascular Index.